Second Anniversary of COVID-19 – ´Building Back Better´ Encounters New Challenges 11/03/2022 Raisa Santos & Elaine Ruth Fletcher Two years after the World Health Organization declared the novel coronavirus outbreak a global pandemic on 11 March 2022, the developed world’s long-time fixation on the SARS-CoV2 virus, which has killed 6 million people, has suddenly shifted away from health to the war in Ukraine and sharply rising geopolitical tensions. Meanwhile high-income countries have dropped […] Continue reading -> Mariupol Maternity Hospital Bombed, as Scientists Warn of Looming Nuclear Danger 09/03/2022 Kerry Cullinan A maternity and children´s hospital in the southern Ukranian city of Mariupol was bombed Wednesday, reportedly injuring 17 people, while WHO warned that Ukrainians who manage to escape direct injury in Russian bombings and shellings face hypothermia, frostbite and respiratory diseases, as well as conflict-related trauma – while the lack of access to treatment for […] Continue reading -> Moderna Waives its COVID Patents Permanently – But Won’t Share Tech with South African mRNA Hub 08/03/2022 Kerry Cullinan Moderna has committed to permanently waiving its COVID-19 patents in 92 low- and middle-income countries, and is pursuing vaccines for 15 diseases identified as the world’s biggest public health risk, including ebola, tuberculosis and malaria. The company has also offered outside researchers access to its mRNA technology to pursue research on emerging and neglected infectious […] Continue reading -> WHO Warns of ‘Humanitarian Catastrophe’ as it Releases $3.5 Million in Aid to Ukraine 25/02/2022 Maayan Hoffman & Elaine Ruth Fletcher The World Health Organization said it had released $3.5 million to support delivery of urgent medical supplies to the people of Ukraine, after Russia invaded the country on three fronts simultaneously early Thursday morning. Meanwhile, WHO’s European Regional Office called for an end to hostilities saying: “any further escalation could result in a humanitarian catastrophe […] Continue reading -> Eliminating Viral Hepatitis in Europe is Possible – Soon 25/02/2022 Maria Buti Somewhere between 10 and 14 million people are living with viral hepatitis B (HBV) or hepatitis C (HCV) in WHO’s European region alone. And over three quarters of those people do not even know they have either disease. It’s no surprise then, that approximately 300 people die each day due to HBV and HCV -related […] Continue reading -> Global Fund Seeks Substantial Budget Increase to Offset Impact of COVID on TB, HIV and Malaria 23/02/2022 Kerry Cullinan The Global Fund to Fight AIDS, Tuberculosis and Malaria is seeking $18-billion for its next three-year funding cycle – a $4billion increase over the previous period – in part to offset the impact of COVID-19. “In the face of the catastrophic impact of COVID-19 on the fight against HIV, TB and malaria, the choice is […] Continue reading -> Finally Cause for Optimism About TB Vaccine Research, Says Fauci 22/02/2022 Kerry Cullinan There is finally “cause for optimism” in the quest for a tuberculosis vaccine, Dr Anthony Fauci, director of the US National Institute of Allergy and Infectious Disease (NIAD), told the opening of the sixth Global Forum on TB Vaccines on Tuesday. Before the COVID-19 pandemic, TB was the most deadly global infectious disease yet there […] Continue reading -> Flagship Training Programme Boosts Research in Neglected Tropical Diseases in Global South 21/02/2022 Kerry Cullinan In a village in eastern Ghana where Comfort Tetteh grew up, many people thought it was normal for a child to urinate blood. But after studying public health, Tetteh recognized this as a sign of schistosomiasis, one of the many neglected tropical diseases that affect her community. “In the districts that I’ve worked in, everything […] Continue reading -> BioNTech To Ship Modular mRNA Vaccine Facilities in Containers to African Countries to Jump-start Production 16/02/2022 Elaine Ruth Fletcher The German-based BioNTech, which co-developed with Pfizer an mRNA COVID vaccine, said on Wednesday that it will set up modular “turnkey” mRNA vaccine facilities to produce the vaccine in Rwanda and Senegal in 2022 – with a fill-and-finish collaboration in Ghana as well. South Africa, which is the new hub for the WHO-supported mRNA vaccine […] Continue reading -> Infectious Disease Funding Virtually Unchanged, Neglected Tropical Diseases Continue Trend of Stagnation 28/01/2022 Raisa Santos Despite the strains of COVID-19, global funding for poverty-related infectious diseases, such as HIV/AIDS, TB, and malaria, remains virtually unchanged at US $3.937 billion, with investment dropping only 4% in 2020, according to the fourteenth annual G-FINDER Report. The report, released by Australia-based Policy Cures Research group on Thursday, showed a drop of only US […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Mariupol Maternity Hospital Bombed, as Scientists Warn of Looming Nuclear Danger 09/03/2022 Kerry Cullinan A maternity and children´s hospital in the southern Ukranian city of Mariupol was bombed Wednesday, reportedly injuring 17 people, while WHO warned that Ukrainians who manage to escape direct injury in Russian bombings and shellings face hypothermia, frostbite and respiratory diseases, as well as conflict-related trauma – while the lack of access to treatment for […] Continue reading -> Moderna Waives its COVID Patents Permanently – But Won’t Share Tech with South African mRNA Hub 08/03/2022 Kerry Cullinan Moderna has committed to permanently waiving its COVID-19 patents in 92 low- and middle-income countries, and is pursuing vaccines for 15 diseases identified as the world’s biggest public health risk, including ebola, tuberculosis and malaria. The company has also offered outside researchers access to its mRNA technology to pursue research on emerging and neglected infectious […] Continue reading -> WHO Warns of ‘Humanitarian Catastrophe’ as it Releases $3.5 Million in Aid to Ukraine 25/02/2022 Maayan Hoffman & Elaine Ruth Fletcher The World Health Organization said it had released $3.5 million to support delivery of urgent medical supplies to the people of Ukraine, after Russia invaded the country on three fronts simultaneously early Thursday morning. Meanwhile, WHO’s European Regional Office called for an end to hostilities saying: “any further escalation could result in a humanitarian catastrophe […] Continue reading -> Eliminating Viral Hepatitis in Europe is Possible – Soon 25/02/2022 Maria Buti Somewhere between 10 and 14 million people are living with viral hepatitis B (HBV) or hepatitis C (HCV) in WHO’s European region alone. And over three quarters of those people do not even know they have either disease. It’s no surprise then, that approximately 300 people die each day due to HBV and HCV -related […] Continue reading -> Global Fund Seeks Substantial Budget Increase to Offset Impact of COVID on TB, HIV and Malaria 23/02/2022 Kerry Cullinan The Global Fund to Fight AIDS, Tuberculosis and Malaria is seeking $18-billion for its next three-year funding cycle – a $4billion increase over the previous period – in part to offset the impact of COVID-19. “In the face of the catastrophic impact of COVID-19 on the fight against HIV, TB and malaria, the choice is […] Continue reading -> Finally Cause for Optimism About TB Vaccine Research, Says Fauci 22/02/2022 Kerry Cullinan There is finally “cause for optimism” in the quest for a tuberculosis vaccine, Dr Anthony Fauci, director of the US National Institute of Allergy and Infectious Disease (NIAD), told the opening of the sixth Global Forum on TB Vaccines on Tuesday. Before the COVID-19 pandemic, TB was the most deadly global infectious disease yet there […] Continue reading -> Flagship Training Programme Boosts Research in Neglected Tropical Diseases in Global South 21/02/2022 Kerry Cullinan In a village in eastern Ghana where Comfort Tetteh grew up, many people thought it was normal for a child to urinate blood. But after studying public health, Tetteh recognized this as a sign of schistosomiasis, one of the many neglected tropical diseases that affect her community. “In the districts that I’ve worked in, everything […] Continue reading -> BioNTech To Ship Modular mRNA Vaccine Facilities in Containers to African Countries to Jump-start Production 16/02/2022 Elaine Ruth Fletcher The German-based BioNTech, which co-developed with Pfizer an mRNA COVID vaccine, said on Wednesday that it will set up modular “turnkey” mRNA vaccine facilities to produce the vaccine in Rwanda and Senegal in 2022 – with a fill-and-finish collaboration in Ghana as well. South Africa, which is the new hub for the WHO-supported mRNA vaccine […] Continue reading -> Infectious Disease Funding Virtually Unchanged, Neglected Tropical Diseases Continue Trend of Stagnation 28/01/2022 Raisa Santos Despite the strains of COVID-19, global funding for poverty-related infectious diseases, such as HIV/AIDS, TB, and malaria, remains virtually unchanged at US $3.937 billion, with investment dropping only 4% in 2020, according to the fourteenth annual G-FINDER Report. The report, released by Australia-based Policy Cures Research group on Thursday, showed a drop of only US […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Moderna Waives its COVID Patents Permanently – But Won’t Share Tech with South African mRNA Hub 08/03/2022 Kerry Cullinan Moderna has committed to permanently waiving its COVID-19 patents in 92 low- and middle-income countries, and is pursuing vaccines for 15 diseases identified as the world’s biggest public health risk, including ebola, tuberculosis and malaria. The company has also offered outside researchers access to its mRNA technology to pursue research on emerging and neglected infectious […] Continue reading -> WHO Warns of ‘Humanitarian Catastrophe’ as it Releases $3.5 Million in Aid to Ukraine 25/02/2022 Maayan Hoffman & Elaine Ruth Fletcher The World Health Organization said it had released $3.5 million to support delivery of urgent medical supplies to the people of Ukraine, after Russia invaded the country on three fronts simultaneously early Thursday morning. Meanwhile, WHO’s European Regional Office called for an end to hostilities saying: “any further escalation could result in a humanitarian catastrophe […] Continue reading -> Eliminating Viral Hepatitis in Europe is Possible – Soon 25/02/2022 Maria Buti Somewhere between 10 and 14 million people are living with viral hepatitis B (HBV) or hepatitis C (HCV) in WHO’s European region alone. And over three quarters of those people do not even know they have either disease. It’s no surprise then, that approximately 300 people die each day due to HBV and HCV -related […] Continue reading -> Global Fund Seeks Substantial Budget Increase to Offset Impact of COVID on TB, HIV and Malaria 23/02/2022 Kerry Cullinan The Global Fund to Fight AIDS, Tuberculosis and Malaria is seeking $18-billion for its next three-year funding cycle – a $4billion increase over the previous period – in part to offset the impact of COVID-19. “In the face of the catastrophic impact of COVID-19 on the fight against HIV, TB and malaria, the choice is […] Continue reading -> Finally Cause for Optimism About TB Vaccine Research, Says Fauci 22/02/2022 Kerry Cullinan There is finally “cause for optimism” in the quest for a tuberculosis vaccine, Dr Anthony Fauci, director of the US National Institute of Allergy and Infectious Disease (NIAD), told the opening of the sixth Global Forum on TB Vaccines on Tuesday. Before the COVID-19 pandemic, TB was the most deadly global infectious disease yet there […] Continue reading -> Flagship Training Programme Boosts Research in Neglected Tropical Diseases in Global South 21/02/2022 Kerry Cullinan In a village in eastern Ghana where Comfort Tetteh grew up, many people thought it was normal for a child to urinate blood. But after studying public health, Tetteh recognized this as a sign of schistosomiasis, one of the many neglected tropical diseases that affect her community. “In the districts that I’ve worked in, everything […] Continue reading -> BioNTech To Ship Modular mRNA Vaccine Facilities in Containers to African Countries to Jump-start Production 16/02/2022 Elaine Ruth Fletcher The German-based BioNTech, which co-developed with Pfizer an mRNA COVID vaccine, said on Wednesday that it will set up modular “turnkey” mRNA vaccine facilities to produce the vaccine in Rwanda and Senegal in 2022 – with a fill-and-finish collaboration in Ghana as well. South Africa, which is the new hub for the WHO-supported mRNA vaccine […] Continue reading -> Infectious Disease Funding Virtually Unchanged, Neglected Tropical Diseases Continue Trend of Stagnation 28/01/2022 Raisa Santos Despite the strains of COVID-19, global funding for poverty-related infectious diseases, such as HIV/AIDS, TB, and malaria, remains virtually unchanged at US $3.937 billion, with investment dropping only 4% in 2020, according to the fourteenth annual G-FINDER Report. The report, released by Australia-based Policy Cures Research group on Thursday, showed a drop of only US […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Warns of ‘Humanitarian Catastrophe’ as it Releases $3.5 Million in Aid to Ukraine 25/02/2022 Maayan Hoffman & Elaine Ruth Fletcher The World Health Organization said it had released $3.5 million to support delivery of urgent medical supplies to the people of Ukraine, after Russia invaded the country on three fronts simultaneously early Thursday morning. Meanwhile, WHO’s European Regional Office called for an end to hostilities saying: “any further escalation could result in a humanitarian catastrophe […] Continue reading -> Eliminating Viral Hepatitis in Europe is Possible – Soon 25/02/2022 Maria Buti Somewhere between 10 and 14 million people are living with viral hepatitis B (HBV) or hepatitis C (HCV) in WHO’s European region alone. And over three quarters of those people do not even know they have either disease. It’s no surprise then, that approximately 300 people die each day due to HBV and HCV -related […] Continue reading -> Global Fund Seeks Substantial Budget Increase to Offset Impact of COVID on TB, HIV and Malaria 23/02/2022 Kerry Cullinan The Global Fund to Fight AIDS, Tuberculosis and Malaria is seeking $18-billion for its next three-year funding cycle – a $4billion increase over the previous period – in part to offset the impact of COVID-19. “In the face of the catastrophic impact of COVID-19 on the fight against HIV, TB and malaria, the choice is […] Continue reading -> Finally Cause for Optimism About TB Vaccine Research, Says Fauci 22/02/2022 Kerry Cullinan There is finally “cause for optimism” in the quest for a tuberculosis vaccine, Dr Anthony Fauci, director of the US National Institute of Allergy and Infectious Disease (NIAD), told the opening of the sixth Global Forum on TB Vaccines on Tuesday. Before the COVID-19 pandemic, TB was the most deadly global infectious disease yet there […] Continue reading -> Flagship Training Programme Boosts Research in Neglected Tropical Diseases in Global South 21/02/2022 Kerry Cullinan In a village in eastern Ghana where Comfort Tetteh grew up, many people thought it was normal for a child to urinate blood. But after studying public health, Tetteh recognized this as a sign of schistosomiasis, one of the many neglected tropical diseases that affect her community. “In the districts that I’ve worked in, everything […] Continue reading -> BioNTech To Ship Modular mRNA Vaccine Facilities in Containers to African Countries to Jump-start Production 16/02/2022 Elaine Ruth Fletcher The German-based BioNTech, which co-developed with Pfizer an mRNA COVID vaccine, said on Wednesday that it will set up modular “turnkey” mRNA vaccine facilities to produce the vaccine in Rwanda and Senegal in 2022 – with a fill-and-finish collaboration in Ghana as well. South Africa, which is the new hub for the WHO-supported mRNA vaccine […] Continue reading -> Infectious Disease Funding Virtually Unchanged, Neglected Tropical Diseases Continue Trend of Stagnation 28/01/2022 Raisa Santos Despite the strains of COVID-19, global funding for poverty-related infectious diseases, such as HIV/AIDS, TB, and malaria, remains virtually unchanged at US $3.937 billion, with investment dropping only 4% in 2020, according to the fourteenth annual G-FINDER Report. The report, released by Australia-based Policy Cures Research group on Thursday, showed a drop of only US […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Eliminating Viral Hepatitis in Europe is Possible – Soon 25/02/2022 Maria Buti Somewhere between 10 and 14 million people are living with viral hepatitis B (HBV) or hepatitis C (HCV) in WHO’s European region alone. And over three quarters of those people do not even know they have either disease. It’s no surprise then, that approximately 300 people die each day due to HBV and HCV -related […] Continue reading -> Global Fund Seeks Substantial Budget Increase to Offset Impact of COVID on TB, HIV and Malaria 23/02/2022 Kerry Cullinan The Global Fund to Fight AIDS, Tuberculosis and Malaria is seeking $18-billion for its next three-year funding cycle – a $4billion increase over the previous period – in part to offset the impact of COVID-19. “In the face of the catastrophic impact of COVID-19 on the fight against HIV, TB and malaria, the choice is […] Continue reading -> Finally Cause for Optimism About TB Vaccine Research, Says Fauci 22/02/2022 Kerry Cullinan There is finally “cause for optimism” in the quest for a tuberculosis vaccine, Dr Anthony Fauci, director of the US National Institute of Allergy and Infectious Disease (NIAD), told the opening of the sixth Global Forum on TB Vaccines on Tuesday. Before the COVID-19 pandemic, TB was the most deadly global infectious disease yet there […] Continue reading -> Flagship Training Programme Boosts Research in Neglected Tropical Diseases in Global South 21/02/2022 Kerry Cullinan In a village in eastern Ghana where Comfort Tetteh grew up, many people thought it was normal for a child to urinate blood. But after studying public health, Tetteh recognized this as a sign of schistosomiasis, one of the many neglected tropical diseases that affect her community. “In the districts that I’ve worked in, everything […] Continue reading -> BioNTech To Ship Modular mRNA Vaccine Facilities in Containers to African Countries to Jump-start Production 16/02/2022 Elaine Ruth Fletcher The German-based BioNTech, which co-developed with Pfizer an mRNA COVID vaccine, said on Wednesday that it will set up modular “turnkey” mRNA vaccine facilities to produce the vaccine in Rwanda and Senegal in 2022 – with a fill-and-finish collaboration in Ghana as well. South Africa, which is the new hub for the WHO-supported mRNA vaccine […] Continue reading -> Infectious Disease Funding Virtually Unchanged, Neglected Tropical Diseases Continue Trend of Stagnation 28/01/2022 Raisa Santos Despite the strains of COVID-19, global funding for poverty-related infectious diseases, such as HIV/AIDS, TB, and malaria, remains virtually unchanged at US $3.937 billion, with investment dropping only 4% in 2020, according to the fourteenth annual G-FINDER Report. The report, released by Australia-based Policy Cures Research group on Thursday, showed a drop of only US […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Global Fund Seeks Substantial Budget Increase to Offset Impact of COVID on TB, HIV and Malaria 23/02/2022 Kerry Cullinan The Global Fund to Fight AIDS, Tuberculosis and Malaria is seeking $18-billion for its next three-year funding cycle – a $4billion increase over the previous period – in part to offset the impact of COVID-19. “In the face of the catastrophic impact of COVID-19 on the fight against HIV, TB and malaria, the choice is […] Continue reading -> Finally Cause for Optimism About TB Vaccine Research, Says Fauci 22/02/2022 Kerry Cullinan There is finally “cause for optimism” in the quest for a tuberculosis vaccine, Dr Anthony Fauci, director of the US National Institute of Allergy and Infectious Disease (NIAD), told the opening of the sixth Global Forum on TB Vaccines on Tuesday. Before the COVID-19 pandemic, TB was the most deadly global infectious disease yet there […] Continue reading -> Flagship Training Programme Boosts Research in Neglected Tropical Diseases in Global South 21/02/2022 Kerry Cullinan In a village in eastern Ghana where Comfort Tetteh grew up, many people thought it was normal for a child to urinate blood. But after studying public health, Tetteh recognized this as a sign of schistosomiasis, one of the many neglected tropical diseases that affect her community. “In the districts that I’ve worked in, everything […] Continue reading -> BioNTech To Ship Modular mRNA Vaccine Facilities in Containers to African Countries to Jump-start Production 16/02/2022 Elaine Ruth Fletcher The German-based BioNTech, which co-developed with Pfizer an mRNA COVID vaccine, said on Wednesday that it will set up modular “turnkey” mRNA vaccine facilities to produce the vaccine in Rwanda and Senegal in 2022 – with a fill-and-finish collaboration in Ghana as well. South Africa, which is the new hub for the WHO-supported mRNA vaccine […] Continue reading -> Infectious Disease Funding Virtually Unchanged, Neglected Tropical Diseases Continue Trend of Stagnation 28/01/2022 Raisa Santos Despite the strains of COVID-19, global funding for poverty-related infectious diseases, such as HIV/AIDS, TB, and malaria, remains virtually unchanged at US $3.937 billion, with investment dropping only 4% in 2020, according to the fourteenth annual G-FINDER Report. The report, released by Australia-based Policy Cures Research group on Thursday, showed a drop of only US […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Finally Cause for Optimism About TB Vaccine Research, Says Fauci 22/02/2022 Kerry Cullinan There is finally “cause for optimism” in the quest for a tuberculosis vaccine, Dr Anthony Fauci, director of the US National Institute of Allergy and Infectious Disease (NIAD), told the opening of the sixth Global Forum on TB Vaccines on Tuesday. Before the COVID-19 pandemic, TB was the most deadly global infectious disease yet there […] Continue reading -> Flagship Training Programme Boosts Research in Neglected Tropical Diseases in Global South 21/02/2022 Kerry Cullinan In a village in eastern Ghana where Comfort Tetteh grew up, many people thought it was normal for a child to urinate blood. But after studying public health, Tetteh recognized this as a sign of schistosomiasis, one of the many neglected tropical diseases that affect her community. “In the districts that I’ve worked in, everything […] Continue reading -> BioNTech To Ship Modular mRNA Vaccine Facilities in Containers to African Countries to Jump-start Production 16/02/2022 Elaine Ruth Fletcher The German-based BioNTech, which co-developed with Pfizer an mRNA COVID vaccine, said on Wednesday that it will set up modular “turnkey” mRNA vaccine facilities to produce the vaccine in Rwanda and Senegal in 2022 – with a fill-and-finish collaboration in Ghana as well. South Africa, which is the new hub for the WHO-supported mRNA vaccine […] Continue reading -> Infectious Disease Funding Virtually Unchanged, Neglected Tropical Diseases Continue Trend of Stagnation 28/01/2022 Raisa Santos Despite the strains of COVID-19, global funding for poverty-related infectious diseases, such as HIV/AIDS, TB, and malaria, remains virtually unchanged at US $3.937 billion, with investment dropping only 4% in 2020, according to the fourteenth annual G-FINDER Report. The report, released by Australia-based Policy Cures Research group on Thursday, showed a drop of only US […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Flagship Training Programme Boosts Research in Neglected Tropical Diseases in Global South 21/02/2022 Kerry Cullinan In a village in eastern Ghana where Comfort Tetteh grew up, many people thought it was normal for a child to urinate blood. But after studying public health, Tetteh recognized this as a sign of schistosomiasis, one of the many neglected tropical diseases that affect her community. “In the districts that I’ve worked in, everything […] Continue reading -> BioNTech To Ship Modular mRNA Vaccine Facilities in Containers to African Countries to Jump-start Production 16/02/2022 Elaine Ruth Fletcher The German-based BioNTech, which co-developed with Pfizer an mRNA COVID vaccine, said on Wednesday that it will set up modular “turnkey” mRNA vaccine facilities to produce the vaccine in Rwanda and Senegal in 2022 – with a fill-and-finish collaboration in Ghana as well. South Africa, which is the new hub for the WHO-supported mRNA vaccine […] Continue reading -> Infectious Disease Funding Virtually Unchanged, Neglected Tropical Diseases Continue Trend of Stagnation 28/01/2022 Raisa Santos Despite the strains of COVID-19, global funding for poverty-related infectious diseases, such as HIV/AIDS, TB, and malaria, remains virtually unchanged at US $3.937 billion, with investment dropping only 4% in 2020, according to the fourteenth annual G-FINDER Report. The report, released by Australia-based Policy Cures Research group on Thursday, showed a drop of only US […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
BioNTech To Ship Modular mRNA Vaccine Facilities in Containers to African Countries to Jump-start Production 16/02/2022 Elaine Ruth Fletcher The German-based BioNTech, which co-developed with Pfizer an mRNA COVID vaccine, said on Wednesday that it will set up modular “turnkey” mRNA vaccine facilities to produce the vaccine in Rwanda and Senegal in 2022 – with a fill-and-finish collaboration in Ghana as well. South Africa, which is the new hub for the WHO-supported mRNA vaccine […] Continue reading -> Infectious Disease Funding Virtually Unchanged, Neglected Tropical Diseases Continue Trend of Stagnation 28/01/2022 Raisa Santos Despite the strains of COVID-19, global funding for poverty-related infectious diseases, such as HIV/AIDS, TB, and malaria, remains virtually unchanged at US $3.937 billion, with investment dropping only 4% in 2020, according to the fourteenth annual G-FINDER Report. The report, released by Australia-based Policy Cures Research group on Thursday, showed a drop of only US […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Infectious Disease Funding Virtually Unchanged, Neglected Tropical Diseases Continue Trend of Stagnation 28/01/2022 Raisa Santos Despite the strains of COVID-19, global funding for poverty-related infectious diseases, such as HIV/AIDS, TB, and malaria, remains virtually unchanged at US $3.937 billion, with investment dropping only 4% in 2020, according to the fourteenth annual G-FINDER Report. The report, released by Australia-based Policy Cures Research group on Thursday, showed a drop of only US […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy